Chemotherapy vs immunotherapy: which cancer treatment is right for you?
A cancer diagnosis often brings a difficult question for patients and families: which treatment is right? Here is how chemotherapy and immunotherapy differ — and how doctors choose between them.
Overview
A cancer diagnosis often brings a difficult question for patients and families: which treatment is right for you? Chemotherapy and immunotherapy are two of the most discussed options — and they work in very different ways.
How chemotherapy works
Chemotherapy uses medicines that target rapidly dividing cells. It has been a foundation of cancer care for decades and remains essential for many solid tumours and blood cancers.
Because it affects dividing cells more broadly, side effects can include fatigue, hair loss, nausea, and low blood counts. Supportive care helps manage these effects, and many people continue daily life with adjustments during treatment cycles.
How immunotherapy works
Immunotherapy helps the immune system recognise and attack cancer cells. Checkpoint inhibitors are the most widely used class in solid tumours.
Not every cancer responds. Benefit depends on tumour type, biomarkers such as PD-L1 or MSI status, prior treatment, and overall health. Side effects are often different from chemotherapy and may involve inflammation in the skin, gut, lungs, or endocrine glands.
How doctors choose
The choice is rarely chemotherapy or immunotherapy in isolation. Guidelines, pathology, stage, biomarkers, and your fitness all shape the plan. Sometimes both are combined. Sometimes one is clearly better as a first step.
- Confirm the exact cancer type and stage
- Review biomarker and molecular reports when available
- Weigh expected benefit against side-effect profiles
- Consider prior treatments and other health conditions
- Discuss goals — cure, control, or symptom relief — openly
Questions worth asking
Bring your reports to the consultation and ask what each option is trying to achieve. Understanding why a plan was chosen often reduces anxiety more than memorising drug names.
- Is immunotherapy approved for my cancer and stage?
- Do my reports show biomarkers that change the recommendation?
- What side effects should I report immediately?
- How will we know if the treatment is working?
There is no universal “better” treatment — only the better fit for your diagnosis. A clear review of reports with an experienced medical oncologist is the surest way to choose with confidence.
Frequently asked questions
Not always. For some cancers and biomarkers it can work better or longer; for others chemotherapy remains the better first step. The comparison is case-specific.
Yes. In several cancers, chemo-immunotherapy combinations are standard. Your oncologist will explain whether a combination fits your stage and pathology.
Chemotherapy more often causes hair loss, low counts, and nausea. Immunotherapy more often causes inflammatory side effects affecting skin, gut, lungs, thyroid, or other organs.
Often yes for immunotherapy and targeted options. PD-L1, MSI status, and molecular panels can change which pathway is recommended first.